Apollon Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$263K Buy
2,910
+408
+16% +$37.4K ﹤0.01% 1177
2025
Q4
$225K Sell
2,502
-113
-4% -$10.7K ﹤0.01% 1185
2025
Q3
$258K Buy
2,615
+133
+5% +$13.2K ﹤0.01% 1111
2025
Q2
$226K Sell
2,482
-392
-14% -$37.9K ﹤0.01% 1127
2025
Q1
$325K Buy
2,874
+16
+0.6% +$1.71K 0.01% 929
2024
Q4
$302K Sell
2,858
-726
-20% -$77.9K 0.01% 937
2024
Q3
$387K Sell
3,584
-459
-11% -$50.1K 0.01% 818
2024
Q2
$439K Buy
4,043
+42
+1% +$4.95K 0.01% 731
2024
Q1
$528K Sell
4,001
-84
-2% -$10.5K 0.02% 679
2023
Q4
$497K Buy
4,085
+1,898
+87% +$212K 0.02% 653
2023
Q3
$245K Sell
2,187
-327
-13% -$41.5K 0.01% 766
2023
Q2
$366K Sell
2,514
-154
-6% -$20.9K 0.02% 686
2023
Q1
$345K Buy
2,668
+112
+4% +$14.1K 0.02% 641
2022
Q4
$326K Sell
2,556
-349
-12% -$40.5K 0.02% 643
2022
Q3
$304K Sell
2,905
-420
-13% -$46.1K 0.03% 594
2022
Q2
$349K Sell
3,325
-1,436
-30% -$170K 0.03% 529
2022
Q1
$609K Buy
4,761
+264
+6% +$31.8K 0.04% 407
2021
Q4
$554K Buy
+4,497
New +$589K 0.04% 436
2020
Q3
Sell
-515
Closed -$60K 708
2020
Q2
$60K Buy
+515
New +$59.3K 0.03% 225

Other funds holding ZBH

Apollon Wealth Management's ZBH Position: Q1 2026 in Review

Apollon Wealth Management increased its Zimmer Biomet (ZBH) stake by 16% in Q1 2026, buying an estimated $37.4K and bringing the position to 2,910 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Apollon Wealth Management first reported a position in ZBH in Q2 2020 and has held it in 19 quarters since. The position peaked at $609K in Q1 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Apollon Wealth Management held 2,910 shares of Zimmer Biomet worth $263K as of Q1 2026.
  • Apollon Wealth Management bought 408 Zimmer Biomet shares in Q1 2026, an estimated $37.4K.
  • Zimmer Biomet made up ﹤0.01% of Apollon Wealth Management's portfolio in Q1 2026, its #1177 holding.
  • Apollon Wealth Management first reported a position in Zimmer Biomet in Q2 2020 and has held it in 19 quarters since.
  • Apollon Wealth Management's Zimmer Biomet position peaked at $609K in Q1 2022.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.